FDA Considers Reducing UDI Direct Marking Requirements For Implants

FDA Considers Reducing UDI Direct Marking Requirements For Implants-thegraysheet: Jay Crowley, FDA’s senior advisor for patient safety and the lead official on the developing UDI program, provided an overview of some of FDA plans for the upcoming final UDI rule during a May 1 session at the Medical Device Conference, co-sponsored by FDA and Xavier University in Cincinnati. The proposed rule was released last July, and FDA received more than 250 comments, some of which made convincing arguments for changes, Crowley said.